Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × Curcumin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Multiple Myeloma 2 Uterine Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Sezary Syndrome 1 Rectal Neoplasms 1 Radiodermatitis 1 Prostate Cancer Metastatic Castration Resistant 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Gastritis, Atrophic 1 Fatigue 1 Endometrial Neoplasms 1 Communicable Diseases 1 Colorectal Neoplasms 1 Carcinoma 1

Interventions

Cisplatin 113 Radiotherapy 71 Cetuximab 68 Docetaxel 50 Paclitaxel 41 pembrolizumab 39 Carboplatin 39 Fluorouracil 38 Radiotherapy, Intensity-Modulated 30 Drug Therapy 15 Radiation 13 Gefitinib 13 Nivolumab 11 Gemcitabine 11 Surgical Procedures, Operative 10 Bevacizumab 10 Amifostine 9 tislelizumab 8 Pemetrexed 8 Oxaliplatin 8 Erlotinib Hydrochloride 8 Celecoxib 8 Capecitabine 8 durvalumab 7 atezolizumab 7 Filgrastim 7 Panitumumab 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04208334 2023-03-28

CurChexia

Phramongkutklao College of Medicine and Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡